Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    

ALLERGAN, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on ALLERGAN, INC.
2017Mylan defends chairman to ISS ahead of June 22 investor vote
RE
2017ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Soci..
PU
2017FEATURED COMPANY NEWS - MYLAN LAUNCH : Generic Reclast® Injection and Generic Az..
AQ
2017U.S. state, local government lawsuits over opioids face uphill battle
RE
2017ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 201..
PU
2017ALLERGAN PLC : Entry into a Material Definitive Agreement, Other Events, Financi..
AQ
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch R..
PU
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017HEALTH CANADA APPROVES ALLERGAN PLC : AGN) IBS Drug Viberzi
AQ
2017ALLERGAN : Eyepowerment™ Campaign Releases Survey Revealing the Importance..
PU
2017ALLERGAN : VIBERZI™ Now Approved in Canada for patients with irritable bow..
AQ
2017Several top fund managers trim Allergan stakes in first quarter
RE
2017CARL ICAHN : Icahn takes new 19.8 million share stake in Conduent in first quart..
RE
2017High-profile Snap stakeholders revealed in filings
RE
2017High-profile Snap stakeholders revealed in filings
RE
2017ALLERGAN, INC. : Today's Research Reports on Stocks to Watch: Allergan and Celge..
AC
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
2017Allergan posts loss as it writes down Teva holdings
RE
2017Allergan posts loss as it writes down Teva holdings
RE
2017Sanofi pegs U.S. drug price rises to below healthcare inflation
RE
2017ALLERGAN PLC (NYSE : AGN) reported earnings of $3.35 per share beating Walls Str..
AQ
2017ALLERGAN PLC (NYSE : AGN) Files An 8-K Results of Operations and Financial Condi..
AQ
2017ALLERGAN PLC : Results of Operations and Financial Condition, Financial Statemen..
AQ
2017ALLERGAN : tops Street 1Q forecasts, deal fuels guidance hike
AQ
2017ALLERGAN PLC (NYSE : AGN) Files An 8-K Submission of Matters to a Vote of Securi..
AQ
2017ALLERGAN PLC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2017ALLERGAN : to Present New Data at the 2017 American College of Obstetricians and..
PU
2017ALLERGAN : Successfully Completes ZELTIQ Aesthetics Acquisition
AQ
2017NOVARTIS : Allergan Expands Leading Research & Development NASH Program with Nov..
AQ
2017ALLERGAN : Granted Marketing Authorization by the FDA for TrueTear, the First In..
AQ
2017ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Millio..
PU
2017ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to S..
PU
2017ALLERGAN : Teams Up With Media Mogul Wendy Williams to Debut the Patient Empower..
PU
2017ALLERGAN, INC. : Blog Coverage Allergan and Paratek's Acne Drug Reported Positiv..
AC
2017ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Oph..
PU
2017ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Fac..
PU
2017ALLERGAN : New Survey Reveals Impact Of Double Chin On Self-Perception And Behav..
PU
2017ALLERGAN : New Eyepowerment™ Campaign Urges The Up To 33 Million Americans..
PU
2017Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
RE
2017ALLERGAN, INC. : Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence ..
AC
2017Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
RE
2017Stada to hold takeover talks with rival suitors Cinven and Advent
RE
2017Allergan says U.S. tax reform unlikely in 2017, sees strong year
RE
2017ALLERGAN : Launches See America(SM), a Bold Initiative Furthering the Fight Agai..
PU
2017ALLERGAN : Launches Juvéderm® Volite - an Innovative Injectable Treatment Design..
PU
2017ALLERGAN : U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (l..
PU
2017U.S. reaches settlement with Endo on pay-for-delay charges
RE
2017ALLERGAN : Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride..
PU
2017Allergan to pay $15 million over failing to disclose merger talks
RE
2017ALLERGAN : and Gedeon Richter Announce Positive Phase III Results for Ulipristal..
PU
2017Pharma company executives debate drug pricing increases
RE
2017ABRAHAM, FRUCHTER & TWERSKY, LLP FIL : Agn)
MW
2017ALLERGAN, INC. : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Inv..
AC
2016ALLERGAN, INC. : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses I..
AC
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
AC
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
AC
2016ALLERGAN, INC. : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses i..
AC
2016Actavis UK raised drug prices 12,000 percent, watchdog finds
RE
2016U.S. states sue Mylan, Teva, others for fixing drug prices
RE
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016ALLERGAN, INC. : Pomerantz Law Firm Reminds Shareholders with Losses on their In..
AC
2016ALLERGAN, INC. : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
AC
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016ALLERGAN, INC. : Pomerantz Law Firm Reminds Shareholders with Losses on their In..
AC
2016Pharma execs weigh in on possible changes under Trump
RE
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016Lilly's drug for Alzheimer's fails big trial; shares drop
RE
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
AC
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class ..
AC
2016ALLERGAN : Announces Partnership with Amy Dixon, Elite Paratriathlete, to Improv..
PU
2016Teva trims 2016 outlook on drug launch delays
RE
2016ALLERGAN, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
AC
1  2  3  4  5  6  7  8  9  10Next
Chart ALLERGAN, INC.
Duration : Period :
Allergan, Inc. Technical Analysis Chart | US0184901025 | 4-Traders
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
David Nakasone Investor Relations Contact
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.0
JOHNSON & JOHNSON-8.71%339 783
PFIZER0.86%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571